461 related articles for article (PubMed ID: 33288885)
21. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
Ma X; Wang B; Wang X; Luo Y; Fan W
PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer.
Xu M; Qin S; Cao F; Ding S; Li M
Int J Oncol; 2017 Sep; 51(3):867-876. PubMed ID: 28713929
[TBL] [Abstract][Full Text] [Related]
23. Extracellular matrix protein 1 promotes cell metastasis and glucose metabolism by inducing integrin β4/FAK/SOX2/HIF-1α signaling pathway in gastric cancer.
Gan L; Meng J; Xu M; Liu M; Qi Y; Tan C; Wang Y; Zhang P; Weng W; Sheng W; Huang M; Wang Z
Oncogene; 2018 Feb; 37(6):744-755. PubMed ID: 29059156
[TBL] [Abstract][Full Text] [Related]
24. GREM2 maintains stem cell-like phenotypes in gastric cancer cells by regulating the JNK signaling pathway.
Ran A; Guan L; Wang J; Wang Y
Cell Cycle; 2019 Oct; 18(19):2414-2431. PubMed ID: 31345097
[TBL] [Abstract][Full Text] [Related]
25. TBL1XR1 induces cell proliferation and inhibit cell apoptosis by the PI3K/AKT pathway in pancreatic ductal adenocarcinoma.
Gu JF; Fu W; Qian HX; Gu WX; Zong Y; Chen Q; Lu L
World J Gastroenterol; 2020 Jul; 26(25):3586-3602. PubMed ID: 32742128
[TBL] [Abstract][Full Text] [Related]
26. FPR2 promotes invasion and metastasis of gastric cancer cells and predicts the prognosis of patients.
Hou XL; Ji CD; Tang J; Wang YX; Xiang DF; Li HQ; Liu WW; Wang JX; Yan HZ; Wang Y; Zhang P; Cui YH; Wang JM; Bian XW; Liu W
Sci Rep; 2017 Jun; 7(1):3153. PubMed ID: 28600569
[TBL] [Abstract][Full Text] [Related]
27. miR-492 promotes chemoresistance to CDDP and metastasis by targeting inhibiting DNMT3B and induces stemness in gastric cancer.
Wu S; Xie J; Shi H; Wang ZW
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32065219
[TBL] [Abstract][Full Text] [Related]
28. SPARC expression is negatively correlated with clinicopathological factors of gastric cancer and inhibits malignancy of gastric cancer cells.
Zhang J; Wang P; Zhu J; Wang W; Yin J; Zhang C; Chen Z; Sun L; Wan Y; Wang X; Chen G; Liu Y
Oncol Rep; 2014 May; 31(5):2312-20. PubMed ID: 24676680
[TBL] [Abstract][Full Text] [Related]
29. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB
J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349
[TBL] [Abstract][Full Text] [Related]
30. Ubiquitin ligase Cbl-b represses IGF-I-induced epithelial mesenchymal transition via ZEB2 and microRNA-200c regulation in gastric cancer cells.
Li H; Xu L; Li C; Zhao L; Ma Y; Zheng H; Li Z; Zhang Y; Wang R; Liu Y; Qu X
Mol Cancer; 2014 Jun; 13():136. PubMed ID: 24885194
[TBL] [Abstract][Full Text] [Related]
31. Hyaluronan-mediated motility receptor confers resistance to chemotherapy
Zhang H; Ren L; Ding Y; Li F; Chen X; Ouyang Y; Zhang Y; Zhang D
FASEB J; 2019 May; 33(5):6365-6377. PubMed ID: 30802150
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of TBL1XR1 in predicting liver metastasis for early stage colorectal cancer.
Liu H; Xu Y; Zhang Q; Yang H; Shi W; Liu Z; Li K; Gong Z; Ning S; Li S; Chen Y
Surg Oncol; 2017 Mar; 26(1):13-20. PubMed ID: 28317580
[TBL] [Abstract][Full Text] [Related]
33. SETD8 promotes stemness characteristics and is a potential prognostic biomarker of gastric adenocarcinoma.
Piao L; Che N; Li H; Li M; Feng Y; Liu X; Kim S; Jin Y; Xuan Y
Exp Mol Pathol; 2020 Dec; 117():104560. PubMed ID: 33127342
[TBL] [Abstract][Full Text] [Related]
34. LIPH promotes metastasis by enriching stem-like cells in triple-negative breast cancer.
Zhang Y; Zhu X; Qiao X; Gu X; Xue J; Han Y; Sun L; Cui M; Liu C
J Cell Mol Med; 2020 Aug; 24(16):9125-9134. PubMed ID: 32618099
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein C-II induces EMT to promote gastric cancer peritoneal metastasis via PI3K/AKT/mTOR pathway.
Wang C; Yang Z; Xu E; Shen X; Wang X; Li Z; Yu H; Chen K; Hu Q; Xia X; Liu S; Guan W
Clin Transl Med; 2021 Aug; 11(8):e522. PubMed ID: 34459127
[TBL] [Abstract][Full Text] [Related]
36. lncRNA PVT1 promotes the migration of gastric cancer by functioning as ceRNA of miR-30a and regulating Snail.
Wang L; Xiao B; Yu T; Gong L; Wang Y; Zhang X; Zou Q; Zuo Q
J Cell Physiol; 2021 Jan; 236(1):536-548. PubMed ID: 32557622
[TBL] [Abstract][Full Text] [Related]
37. SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial-mesenchymal transition by β-catenin and Beclin1/autophagy signaling in colorectal cancer.
Zhu Y; Huang S; Chen S; Chen J; Wang Z; Wang Y; Zheng H
Cell Death Dis; 2021 May; 12(5):449. PubMed ID: 33953166
[TBL] [Abstract][Full Text] [Related]
38. microRNA-203 suppresses invasion of gastric cancer cells by targeting ERK1/2/Slug/ E-cadherin signaling.
Gao P; Wang S; Jing F; Zhan J; Wang Y
Cancer Biomark; 2017; 19(1):11-20. PubMed ID: 28269747
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of miRNA‑301a‑3p promotes tumor progression in gastric cancer by suppressing NKRF and activating NF‑κB signaling.
Xu X; Xia Y; Ma J; Li W; Niu N; Li X; Tao H; Xu J; He X
Int J Oncol; 2020 Aug; 57(2):522-532. PubMed ID: 32468020
[TBL] [Abstract][Full Text] [Related]
40. 5-Lipoxygenase promotes epithelial-mesenchymal transition through the ERK signaling pathway in gastric cancer.
Lin H; Weng J; Mei H; Zhuang M; Xiao X; Du F; Lin L; Wu J; Chen Z; Huang Y; Chen F; Wang X
J Gastroenterol Hepatol; 2021 Feb; 36(2):455-466. PubMed ID: 32667711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
